ORCID as entered in ROS

Select Publications
2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378
,2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', Lancet Infectious Diseases, 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, 3
,2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature Reviews Nephrology, 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3
,2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391
,2014, 'The association between peritoneal dialysis modality and peritonitis', Clinical Journal of the American Society of Nephrology, 9, pp. 1091 - 1097, http://dx.doi.org/10.2215/CJN.09730913
,2014, 'The role of monitoring Gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 34, pp. 219 - 226, http://dx.doi.org/10.3747/pdi.2012.00318
,2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35
,2013, 'Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes', Clinical Journal of the American Society of Nephrology, 8, pp. 1556 - 1563, http://dx.doi.org/10.2215/CJN.12361212
,2013, 'A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS - HONEYPOT STUDY', NEPHROLOGY, 18, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3
,2013, 'Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 28, pp. 1899 - 1907, http://dx.doi.org/10.1093/ndt/gft050
,2013, 'The honeypot randomized controlled trial statistical analysis plan', Peritoneal Dialysis International, 33, pp. 426 - 435, http://dx.doi.org/10.3747/pdi.2012.00310
,2013, 'The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand', Clinical Journal of the American Society of Nephrology, 8, pp. 773 - 780, http://dx.doi.org/10.2215/CJN.08770812
,2013, 'End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases', Nephrology Dialysis Transplantation, 28, pp. 455 - 461, http://dx.doi.org/10.1093/ndt/gfs492
,2013, 'Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease', Kidney International, 83, pp. 503 - 510, http://dx.doi.org/10.1038/ki.2012.375
,2013, 'Daily variation in death in patients treated by long-term dialysis: Comparison of in-center hemodialysis to peritoneal and home hemodialysis', American Journal of Kidney Diseases, 61, pp. 96 - 103, http://dx.doi.org/10.1053/j.ajkd.2012.07.008
,2013, 'Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study', Peritoneal Dialysis International, 33, pp. 75 - 85, http://dx.doi.org/10.3747/pdi.2011.00317
,2013, 'The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients', Kidney International, 84, pp. 969 - 979, http://dx.doi.org/10.1038/ki.2013.190
,2012, 'End-stage kidney disease due to haemolytic uraemic syndrome - Outcomes in 241 consecutive ANZDATA registry cases', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-164
,2012, 'Biocompatible peritoneal dialysis fluids: Clinical outcomes', International Journal of Nephrology, 2012, http://dx.doi.org/10.1155/2012/812609
,2012, 'Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 32, pp. 516 - 524, http://dx.doi.org/10.3747/pdi.2011.00169
,2012, 'NXSTAGE QUEENSLAND HEALTH PILOT PROGRAM THE EARLY AUSTRALIAN NXSTAGE EXPERIENCE: IS NXSTAGE REALLY THE NEXT STAGE IN HOME HAEMODIALYSIS?', NEPHROLOGY, 17, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'TWO CASES OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB', NEPHROLOGY, 17, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: A multi-centre registry study', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-41
,2012, 'A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation', Transplantation, 93, pp. 822 - 826, http://dx.doi.org/10.1097/TP.0b013e318248375a
,2012, 'Overexpression of RAD51 promotes brain metastases from breast cancer', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-5306
,2012, 'Challenges in blood pressure measurement in patients treated with maintenance hemodialysis', American Journal of Kidney Diseases, 60, pp. 463 - 472, http://dx.doi.org/10.1053/j.ajkd.2012.04.026
,2012, 'Recent peritonitis associates with mortality among patients treated with peritoneal dialysis', Journal of the American Society of Nephrology, 23, pp. 1398 - 1405, http://dx.doi.org/10.1681/ASN.2011121135
,2012, 'Repeated peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 59, pp. 84 - 91, http://dx.doi.org/10.1053/j.ajkd.2011.06.018
,2012, 'Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.', Nephrology Dialysis Transplantation Official Publication of the European Dialysis and Transplant Association European Renal Association, 27, pp. 2028 - 2036, http://dx.doi.org/10.1093/ndt/gfr582
,2012, 'Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function', Nephrology Dialysis Transplantation, 27, pp. 381 - 387, http://dx.doi.org/10.1093/ndt/gfr274
,2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966
,2012, 'IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS', Kidney Research and Clinical Practice, 31, pp. A87 - A87, http://dx.doi.org/10.1016/j.krcp.2012.04.606
,2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x
,2011, 'Effect of dialysis modality on survival of hepatitis C-infected ESRF patients', Clinical Journal of the American Society of Nephrology, 6, pp. 2657 - 2661, http://dx.doi.org/10.2215/CJN.02200311
,2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041
,2011, 'Relapsing and recurrent peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 58, pp. 429 - 436, http://dx.doi.org/10.1053/j.ajkd.2011.03.022
,2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186
,2011, 'Frequent versus Standard Hemodialysis', NEW ENGLAND JOURNAL OF MEDICINE, 364, pp. 975 - 976, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288170300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Frequent versus standard hemodialysis.', N Engl J Med, 364, pp. 975, http://dx.doi.org/10.1056/NEJMc1100105
,2011, 'Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?', Nephrology, 16, pp. 144 - 153, http://dx.doi.org/10.1111/j.1440-1797.2010.01407.x
,2010, 'beta-RECEPTOR ANTAGONISTS IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS', NEPHROLOGY, 15, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'INTERVENTIONS FOR ERYTHROPOIETIN-RESISTANT ANAEMIA IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW', NEPHROLOGY, 15, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'RELAPSING AND RECURRENT PERITONEAL DIALYSIS - ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, 15, pp. 57 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'REPEAT PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, 15, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis', Nephrology Dialysis Transplantation, 25, pp. 1973 - 1979, http://dx.doi.org/10.1093/ndt/gfp780
,